Phase IIB Study of Recombinant Novel Coronavirus Vaccine

Clinical trial NCT05293223 · COMPLETED

Trial details

NCT number: NCT05293223
Sponsor: Fundación Huésped
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Vaccine

Start date: 2021-10-01
Primary completion: 2022-11-15
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.